For: |
Gazouli M, Pachoula I, Panayotou I, Mantzaris G, Chrousos G, Anagnou NP, Roma-Giannikou E. |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i14/1753.htm |
Number | Citing Articles |
1 |
Jiun-Sheng Chen, Fulan Hu, Subra Kugathasan, Lynn B Jorde, David Nix, Ann Rutherford, Lee Denson, W Scott Watkins, Sampath Prahalad, Chad Huff, Stephen L Guthery. Targeted Gene Sequencing in Children with Crohn’s Disease and Their Parents: Implications for Missing Heritability. G3 Genes|Genomes|Genetics 2018; 8(9): 2881 doi: 10.1534/g3.118.200404
|
2 |
Kostas A. Triantaphyllopoulos. Long Non-Coding RNAs and Their “Discrete” Contribution to IBD and Johne’s Disease—What Stands out in the Current Picture? A Comprehensive Review. International Journal of Molecular Sciences 2023; 24(17): 13566 doi: 10.3390/ijms241713566
|
3 |
Bruno Lorenzo SCOLARO, Emily dos SANTOS, Leslie Ecker FERREIRA, Paulo Henrique Condeixa de FRANÇA, Harry KLEINUBING, Paulo Gustavo KOTZE, Mauro de Souza Leite PINHO. T300A GENETIC POLYMORPHISM: a susceptibility factor for Crohn’s disease?. Arquivos de Gastroenterologia 2014; 51(2): 97 doi: 10.1590/S0004-28032014000200005
|
4 |
I. Aida, Y. Meddour, H. Kadiri, M. Smara, A. Bousseloub, L. Kecili, L. Gamar, K. Belhocine, M.-A. Boussafsaf, N. Debzi, S. Aouichat-Bouguerra, S. Chaib. T300A variant of AT16L1 gene in a cohort of Algerian Crohn disease patients. Current Research in Translational Medicine 2018; 66(1): 9 doi: 10.1016/j.retram.2018.01.002
|
5 |
Isidora Simovic, Ida Hilmi, Ruey Terng Ng, Kee Seang Chew, Shin Yee Wong, Way Seah Lee, Stephen Riordan, Natalia Castaño‐Rodríguez. ATG16L1 rs2241880/T300A increases susceptibility to perianal Crohn's disease: An updated meta‐analysis on inflammatory bowel disease risk and clinical outcomes. United European Gastroenterology Journal 2024; 12(1): 103 doi: 10.1002/ueg2.12477
|
6 |
Giovanni Latella, Jacopo Di Gregorio, Vincenzo Flati, Florian Rieder, Ian C. Lawrance. Mechanisms of initiation and progression of intestinal fibrosis in IBD. Scandinavian Journal of Gastroenterology 2015; 50(1): 53 doi: 10.3109/00365521.2014.968863
|
7 |
Sara Salvador-Martín, Irene Raposo-Gutiérrez, Víctor Manuel Navas-López, Carmen Gallego-Fernández, Ana Moreno-Álvarez, Alfonso Solar-Boga, Rosana Muñoz-Codoceo, Lorena Magallares, Eva Martínez-Ojinaga, María J. Fobelo, Antonio Millán-Jiménez, Alejandro Rodriguez-Martinez, Concepción A. Vayo, Cesar Sánchez, Mar Tolin, Ferrán Bossacoma, Gemma Pujol-Muncunill, Rafael González de Caldas, Inés Loverdos, José A. Blanca-García, Oscar Segarra, Francisco J. Eizaguirre, Ruth García-Romero, Vicente Merino-Bohórquez, María Sanjurjo-Sáez, Luis A. López-Fernández. Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease. International Journal of Molecular Sciences 2020; 21(9): 3364 doi: 10.3390/ijms21093364
|
8 |
April L. Raftery, Evelyn Tsantikos, Nicola L. Harris, Margaret L. Hibbs. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.02144
|
9 |
Bei-Bei Zhang, Yu Liang, Bo Yang, Ying-Jun Tan. Association between ATG16L1 gene polymorphism and the risk of Crohn’s disease. Journal of International Medical Research 2017; 45(6): 1636 doi: 10.1177/0300060516662404
|
10 |
Carl E.I. Janssen, Carlos D. Rose, Gert De Hertogh, Tammy M. Martin, Brigitte Bader Meunier, Rolando Cimaz, Miroslav Harjacek, Pierre Quartier, Rebecca Ten Cate, Caroline Thomee, Valeer J. Desmet, Alain Fischer, Tania Roskams, Carine H. Wouters. Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2–related disorders Blau syndrome and Crohn disease. Journal of Allergy and Clinical Immunology 2012; 129(4): 1076 doi: 10.1016/j.jaci.2012.02.004
|
11 |
Ian C. Lawrance, Gerhard Rogler, Giorgos Bamias, Christine Breynaert, Jon Florholmen, Gianluca Pellino, Shimon Reif, Silvia Speca, Giovanni Latella. Cellular and Molecular Mediators of Intestinal Fibrosis. Journal of Crohn's and Colitis 2015; : j.crohns.2014.09.008 doi: 10.1016/j.crohns.2014.09.008
|
12 |
Xiaohua Xue, Aimee De Leon-Tabaldo, Rosa Luna-Roman, Glenda Castro, Michael Albers, Freddy Schoetens, Samuel DePrimo, Damayanthi Devineni, Thomas Wilde, Steve Goldberg, Olaf Kinzel, Thomas Hoffmann, Anne M. Fourie, Robin L. Thurmond. Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-90497-9
|
13 |
Yu Shi, Xiao-Feng Luo, Yong-Xin Zhang, Gui-Quan Sun. An indicator of Crohn’s disease severity based on Turing patterns. Chaos, Solitons & Fractals 2023; 171: 113455 doi: 10.1016/j.chaos.2023.113455
|
14 |
Shoor Vir Singh, Kuldeep Dhama, Kundan Kumar Chaubey, Naveen Kumar, Pravin Kumar Singh, Jagdip Singh Sohal, Saurabh Gupta, Ajay Vir Singh, Amit Kumar Verma, Ruchi Tiwari, Mahima ., S. Chakrabort, Rajib Deb. Impact of Host Genetics on Susceptibility and Resistance to Mycobacterium avium Subspecies Paratuberculosis Infection in Domestic Ruminants. Pakistan Journal of Biological Sciences 2013; 16(6): 251 doi: 10.3923/pjbs.2013.251.266
|
15 |
Sara Salvador-Martín, Bartosz Kaczmarczyk, Rebeca Álvarez, Víctor Manuel Navas-López, Carmen Gallego-Fernández, Ana Moreno-Álvarez, Alfonso Solar-Boga, Cesar Sánchez, Mar Tolin, Marta Velasco, Rosana Muñoz-Codoceo, Alejandro Rodriguez-Martinez, Concepción A. Vayo, Ferrán Bossacoma, Gemma Pujol-Muncunill, María J. Fobelo, Antonio Millán-Jiménez, Lorena Magallares, Eva Martínez-Ojinaga, Inés Loverdos, Francisco J. Eizaguirre, José A. Blanca-García, Susana Clemente, Ruth García-Romero, Vicente Merino-Bohórquez, Rafael González de Caldas, Enrique Vázquez, Ana Dopazo, María Sanjurjo-Sáez, Luis A. López-Fernández. Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease. Pharmaceutics 2021; 13(1): 77 doi: 10.3390/pharmaceutics13010077
|
16 |
Caterina Strisciuglio, Renata Auricchio, Massimo Martinelli, Annamaria Staiano, Francesca Paola Giugliano, Marialuisa Andreozzi, Marina De Rosa, Eleonora Giannetti, Carmela Gianfrani, Paola Izzo, Riccardo Troncone, Erasmo Miele. Autophagy genes variants and paediatric Crohn's disease phenotype: A single-centre experience. Digestive and Liver Disease 2014; 46(6): 512 doi: 10.1016/j.dld.2014.02.016
|
17 |
Ji Min Park, Jeongseok Kim, Yoo Jin Lee, Sung Uk Bae, Hye Won Lee. Inflammatory bowel disease–associated intestinal fibrosis. Journal of Pathology and Translational Medicine 2023; 57(1): 60 doi: 10.4132/jptm.2022.11.02
|
18 |
Marta Kaczmarek-Ryś, Szymon Tytus Hryhorowicz, Emilia Lis, Tomasz Banasiewicz, Jacek Paszkowski, Maciej Borejsza-Wysocki, Jarosław Walkowiak, Wojciech Cichy, Piotr Krokowicz, Elżbieta Czkwianianc, Andrzej Hnatyszyn, Iwona Krela-Kaźmierczak, Agnieszka Dobrowolska, Ryszard Słomski, Andrzej Pławski. Crohn’s Disease Susceptibility and Onset Are Strongly Related to Three NOD2 Gene Haplotypes. Journal of Clinical Medicine 2021; 10(17): 3777 doi: 10.3390/jcm10173777
|
19 |
Xiaohua Xue, Pejman Soroosh, Aimee De Leon-Tabaldo, Rosa Luna-Roman, Marciano Sablad, Natasha Rozenkrants, Jingxue Yu, Glenda Castro, Homayon Banie, Wai-Ping Fung-Leung, Luis Santamaria-Babi, Thomas Schlueter, Michael Albers, Kristi Leonard, Alison L. Budelsky, Anne M. Fourie. Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis. Scientific Reports 2016; 6(1) doi: 10.1038/srep37977
|
20 |
Tara M. Connelly, Arthur S. Berg, Leonard Harris, David Brinton, Sue Deiling, Walter A. Koltun. Genetic Determinants Associated With Early Age of Diagnosis of IBD. Diseases of the Colon & Rectum 2015; 58(3): 321 doi: 10.1097/DCR.0000000000000274
|
21 |
Lin Bao, Xuejing Cui, Ru Bai, Chunying Chen. Advancing intestinal organoid technology to decipher nano-intestine interactions and treat intestinal disease. Nano Research 2023; 16(3): 3976 doi: 10.1007/s12274-022-5150-4
|
22 |
Yi Zhu, HongGang Jiang, ZhiHeng Chen, BoHao Lu, Jin Li, XuNing Shen. Genetic association between IL23R rs11209026 and rs10889677 polymorphisms and risk of Crohn’s disease and ulcerative colitis: evidence from 41 studies. Inflammation Research 2020; 69(1): 87 doi: 10.1007/s00011-019-01296-y
|
23 |
Paul Henderson, Craig Stevens. The Role of Autophagy in Crohn’s Disease. Cells 2012; 1(3): 492 doi: 10.3390/cells1030492
|
24 |
Christos A. Grigoras, Panayiotis D. Ziakas, Elamparithi Jayamani, Eleftherios Mylonakis. ATG16L1 and IL23R Variants and Genetic Susceptibility to Crohnʼs Disease. Inflammatory Bowel Diseases 2015; 21(4): 768 doi: 10.1097/MIB.0000000000000305
|
25 |
Clio P Mavragani, Adrianos Nezos, Nikolas Dovrolis, Nikolaos-Panayiotis Andreou, Evangelia Legaki, Leonardo A Sechi, Giorgos Bamias, Maria Gazouli. Type I and II Interferon Signatures Can Predict the Response to Anti-TNF Agents in Inflammatory Bowel Disease Patients: Involvement of the Microbiota. Inflammatory Bowel Diseases 2020; 26(10): 1543 doi: 10.1093/ibd/izaa216
|
26 |
Anton G. Kutikhin. Role of NOD1/CARD4 and NOD2/CARD15 gene polymorphisms in cancer etiology. Human Immunology 2011; 72(10): 955 doi: 10.1016/j.humimm.2011.06.003
|
27 |
Zhaoxiu Liu, Bo Shen. Overcoming difficulty in diagnosis and differential diagnosis of Crohn’s disease: the potential role of serological and genetic tests. Expert Review of Molecular Diagnostics 2015; 15(9): 1133 doi: 10.1586/14737159.2015.1068121
|
28 |
Elham Abdollahi, Fataneh Tavasolian, Amir Abbas Momtazi-Borojeni, Morteza Samadi, Houshang Rafatpanah. Protective role of R381Q (rs11209026) polymorphism in IL-23R gene in immune-mediated diseases: A comprehensive review. Journal of Immunotoxicology 2016; 13(3): 286 doi: 10.3109/1547691X.2015.1115448
|
29 |
Martina Girardelli, Federica Basaldella, Sara Della Paolera, Josef Vuch, Alberto Tommasini, Stefano Martelossi, Sergio Crovella, Anna Monica Bianco. Genetic profile of patients with early onset inflammatory bowel disease. Gene 2018; 645: 18 doi: 10.1016/j.gene.2017.12.029
|
30 |
Mohammad Salem, Mette Ammitzboell, Kris Nys, Jakob Benedict Seidelin, Ole Haagen Nielsen. ATG16L1: A multifunctional susceptibility factor in Crohn disease. Autophagy 2015; 11(4): 585 doi: 10.1080/15548627.2015.1017187
|
31 |
Stephan T Stern, Pavan P Adiseshaiah, Rachael M Crist. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Particle and Fibre Toxicology 2012; 9(1): 20 doi: 10.1186/1743-8977-9-20
|
32 |
Wang-Dong Xu, Qi-Bing Xie, Yi Zhao, Yi Liu. Association of Interleukin-23 receptor gene polymorphisms with susceptibility to Crohn’s disease: A meta-analysis. Scientific Reports 2015; 5(1) doi: 10.1038/srep18584
|
33 |
Anton G. Kutikhin, Arseniy E. Yuzhalin. Genomics of Pattern Recognition Receptors. 2013; : 123 doi: 10.1007/978-3-0348-0688-6_7
|
34 |
Hamish C. K. Angus, A. Grant Butt, Michael Schultz, Roslyn A. Kemp. Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research. Frontiers in Medicine 2020; 6 doi: 10.3389/fmed.2019.00334
|
35 |
Siew C. Ng, Kelvin K.F. Tsoi, Michael A. Kamm, Bing Xia, Justin Wu, Francis K.L. Chan, Joseph J.Y. Sung. Genetics of inflammatory bowel disease in Asia: Systematic review and meta-analysis. Inflammatory Bowel Diseases 2012; 18(6): 1164 doi: 10.1002/ibd.21845
|
36 |
Mohammad Mukim, Mohit Chaturvedi, Rakesh Patel, Supriya Roy, Pratishtha Sharma, Varunesh Chaturvedi, Saloni Goyal, Mohsina F. Patewkar. CROHN’S DISEASE: A REVIEW ON EPIDEMIOLOGY, DIAGNOSIS AND THERAPEUTIC MANAGEMENT. Indian Drugs 2022; 59(09): 16 doi: 10.53879/id.59.09.12577
|